Nanotechnology in Tumor Biomarker Detection: The Potential of Liganded Nanoclusters as Nonlinear Optical Contrast Agents for Molecular Diagnostics of Cancer

被引:39
|
作者
Combes, Guillaume F. [1 ,2 ]
Vuckovic, Ana-Marija [1 ,2 ]
Bakulic, Martina Peric [1 ]
Antoine, Rodolphe [3 ]
Bonacic-Koutecky, Vlasta [1 ,4 ,5 ]
Trajkovic, Katarina [1 ,2 ]
机构
[1] Univ Split, Fac Sci, Ctr Excellence Sci & Technol Integrat Mediterrane, Split 21000, Croatia
[2] Mediterranean Inst Life Sci MedILS, Split 21000, Croatia
[3] Claude Bernard Univ Lyon 1, UMR 5306, Ctr Natl Rech Sci CNRS, F-69622 Villeurbanne, France
[4] Univ Split, Interdisciplinary Ctr Adv Sci & Technol ICAST, Split 21000, Croatia
[5] Humboldt Univ, Chem Dept, D-12489 Berlin, Germany
关键词
tumor biomarker; cancer diagnostics; molecular diagnostics of cancer; liganded noble metal quantum nanocluster; precision medicine; bioimaging; contrast agents; nonlinear optics; two-photon-excited fluorescence; HER2-TARGETED GOLD NANOPARTICLES; METAL NANOCLUSTERS; QUANTUM CLUSTERS; CELLS; SIZE; FLUORESCENCE; TOXICITY; BREAST; STATE; BIODISTRIBUTION;
D O I
10.3390/cancers13164206
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The key factor in preventing premature death from cancer is an early and accurate diagnosis. While common diagnostic procedures are successful in the detection and rough description of a tumor mass, a deeper insight into cancer's molecular features is needed to optimize the treatment and increase the chances of survival. Nanotechnology can aid the molecular diagnostics of cancers through a design of nanomaterials that can simultaneously recognize specific cancer-associated molecules, so-called tumor biomarkers, and allow for their visualization by different imaging techniques. With a recent explosion in the production of various nanomaterials, the selection of the most suitable nanomaterial for tumor biomarker detection becomes a challenge. In this article, we review recent advances in the molecular diagnostics of cancer using nanotechnology and focus on liganded noble metal quantum nanoclusters, a class of ultrasmall nanomaterials with distinctive structural and optical properties, as tools in tumor biomarker detection. Cancer is one of the leading causes of premature death, and, as such, it can be prevented by developing strategies for early and accurate diagnosis. Cancer diagnostics has evolved from the macroscopic detection of malignant tissues to the fine analysis of tumor biomarkers using personalized medicine approaches. Recently, various nanomaterials have been introduced into the molecular diagnostics of cancer. This has resulted in a number of tumor biomarkers that have been detected in vitro and in vivo using nanodevices and corresponding imaging techniques. Atomically precise ligand-protected noble metal quantum nanoclusters represent an interesting class of nanomaterials with a great potential for the detection of tumor biomarkers. They are characterized by high biocompatibility, low toxicity, and suitability for controlled functionalization with moieties specifically recognizing tumor biomarkers. Their non-linear optical properties are of particular importance as they enable the visualization of nanocluster-labeled tumor biomarkers using non-linear optical techniques such as two-photon-excited fluorescence and second harmonic generation. This article reviews liganded nanoclusters among the different nanomaterials used for molecular cancer diagnosis and the relevance of this new class of nanomaterials as non-linear optical probe and contrast agents.
引用
收藏
页数:28
相关论文
共 9 条
  • [1] Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics
    Hellebust, Anne
    Richards-Kortum, Rebecca
    NANOMEDICINE, 2012, 7 (03) : 429 - 445
  • [2] Optical molecular imaging agents for cancer diagnostics and therapeutics
    Kumar, Sonia
    Richards-Kortum, Rebecca
    NANOMEDICINE, 2006, 1 (01) : 23 - 30
  • [3] Optical contrast agents and imaging systems for detection and diagnosis of cancer
    Pierce, Mark C.
    Javier, David J.
    Richards-Kortum, Rebecca
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (09) : 1979 - 1990
  • [4] Optical-based molecular imaging: contrast agents and potential medical applications
    Bremer, C
    Ntziachristos, V
    Weissleder, R
    EUROPEAN RADIOLOGY, 2003, 13 (02) : 231 - 243
  • [5] Confocal microscopy and molecular-specific optical contrast agents for the detection of oral neoplasia
    Carlson, Alicia L.
    Gillenwater, Ann M.
    Williams, Michelle D.
    El-Naggar, Adel K.
    Richards-Kortum, R. R.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2007, 6 (05) : 361 - 374
  • [6] OLA1 is a potential prognostic molecular biomarker for endometrial cancer and promotes tumor progression
    Dong, Yanqi
    Yin, Aiqi
    Xu, Caiqu
    Jiang, Huiping
    Wang, Qinghai
    Wu, Wenjuan
    Guo, Suiqun
    ONCOLOGY LETTERS, 2021, 22 (02)
  • [7] Targeted delivery of cancer-specific multimodal contrast agents for intraoperative detection of tumor boundaries and therapeutic margins
    Xu, Ronald X.
    Xu, Jeff S.
    Huang, Jiwei
    Tweedle, Michael F.
    Schmidt, Carl
    Povoski, Stephen P.
    Martin, Edward W.
    DESIGN AND QUALITY FOR BIOMEDICAL TECHNOLOGIES III, 2010, 7556
  • [8] Delivery of optical contrast agents using Triton-X100, part 2: enhanced mucosal permeation for the detection of cancer biomarkers
    van de Ven, Anne L.
    Adler-Storthz, Karen
    Richards-Kortum, Rebecca
    JOURNAL OF BIOMEDICAL OPTICS, 2009, 14 (02)
  • [9] Rapid detection of exon 2-deleted AIMP2 mutation as a potential biomarker for lung cancer by molecular beacons
    Jo, Seong-Min
    Kim, Youngwook
    Jeong, Young-Su
    Oh, Young Hee
    Park, Keunchil
    Kim, Hak-Sung
    BIOSENSORS & BIOELECTRONICS, 2013, 46 : 142 - 149